Parameswaran N Hari

21PUBLICATIONS
124CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedMedical mycologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 31, 2025
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma.

Nirav N Shah, Alfredo S Colina, Bryon D Johnson

|Nov 22, 2024
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.

Wen Zhu, Yongwei Zheng, Mei Yu

|Sep 19, 2024
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.

Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian

|May 03, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.

Marcelo C Pasquini, Paul K Wallace, Brent Logan

|Apr 22, 2024
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.

Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman

|Mar 05, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.

Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng

Pageof 4

Frequent Collaborators

9 joint publications

Binod Dhakal

5 joint publications

Anita D'Souza

5 joint publications

Saurabh Chhabra

5 joint publications

Siegfried Janz